复发宫颈癌患者放疗后长期骨髓功能随访观察研究
Long-term effects of pelvic radiotherapy on the function of bone marrow in recurrent cervical cancer patients and nursing care
投稿时间:2026-01-03  修订日期:2026-08-14
DOI:
中文关键词:  宫颈癌  放疗  复发  骨髓抑制
英文关键词:Cervical  cancer, radiotherapy, relapse, bone  marrow suppression
基金项目:
作者单位邮编
刘策 首都医科大学附属北京妇产医院 100000
张楠 首都医科大学附属北京妇产医院 北京妇幼保健院 
高宇 首都医科大学附属北京妇产医院 北京妇幼保健院 
邓波儿* 首都医科大学附属北京妇产医院 北京妇幼保健院 100069
孔为民 首都医科大学附属北京妇产医院 北京妇幼保健院 
摘要点击次数: 34
全文下载次数: 9
中文摘要:
      目的:探讨宫颈癌患者既往盆腔放疗史对复发后再次化疗期间,发生骨髓抑制及抑制程度的危险因素。方法:回顾性分析129例复发性宫颈癌患者的临床资料,其中77例既往有盆腔放疗史(观察组),52例无盆腔放疗史(对照组)。分析患者年龄、体重指数、无进展生存期、病理类型、2018年国际妇产科联盟(FIGO)分期、放疗方式等与复发性宫颈癌患者化疗期间骨髓抑制程度的相关性。结果:观察组77例患者中73例(94.8%)化疗后出现骨髓抑制,对照组52例患者中39例(75.0%)发生骨髓抑制(P<0.05)。按照骨髓抑制程度进行分层(III-IV度骨髓抑制为重度骨髓抑制),观察组和对照组发生III-IV度重度骨髓抑制(HT3+)的比例分别为41.6%和13.5%(P<0.05)。单因素分析显示,放疗方式是影响复发性宫颈癌患者III-IV级骨髓抑制发生率的因素(P=0.005)。多因素分析表明,放疗方式及是否进行延伸野照射是发生严重骨髓抑制(III-IV度)的独立危险因素(c2=16.975,P=0.001)。白细胞计数、中性粒细胞绝对值及血小板计数下降是III-IV度骨髓抑制的主要类型。结论:既往盆腔放疗史显著增加复发性宫颈癌患者化疗期间骨髓抑制发生率。对具有放疗史特别是接受过体外放射治疗的复发性宫颈癌患者进行化疗时,需加强护理随访频率以早期发现潜在的严重化疗血液毒性风险,及时干预并帮助完成全程化疗。
英文摘要:
      Purpose: To study the effects of prior pelvic radiotherapy on bone marrow suppression in recurrent cervical cancer patients during chemotherapy. Methods and materials: The cases of 129 patients with recurrent cervical cancer were reviewed, of which 77 patients had pelvic radiotherapy history and another 52 patients with no pelvic radiotherapy history were used as control group. The relationship between age, body mass index, disease free survival, pathological types, FIGO stages, radiotherapy methods and the degree of bone marrow suppression during chemotherapy was statistically analyzed, respectively, for all recurrent cervical cancer patients. Results:Among 77 patients with previous radiotherapy history, 73 recurrent patients (94.8%) had bone marrow suppression followed by chemotherapy. Recurrent cervical cancer patients without prior radiotherapy (n=52) showed a lower risk of bone marrow suppression followed by chemotherapy (n=39, 75.0%, P < 0.05). The probability of severe bone marrow suppression (grade III-IV) after chemotherapy in recurrent cervical patients with or without history of radiotherapy was 41.6% and 13.5%, respectively (P < 0.05). In univariate analysis, radiotherapy methods were associated with the incidence of grade III-IV bone marrow suppression in recurrent cervical cancer patients (P=0.005). In multivariate analysis, radiotherapy methods and extended-field radiotherapy were the risk factor of grade III-IV bone marrow suppression (c2=16.975,P=0.001). No significant differences in the counts of white blood cell, hemoglobin and platelet were observed before chemotherapy at relapse between patients with and without prior radiotherapy. Reduction of white blood cell counts, absolute value of neutrophil cell and platelet counts composited majority type of grade III and IV bone marrow suppression. Conclusions: The prior pelvic radiotherapy significantly increased the incidence of bone marrow suppression during chemotherapy in recurrent cervical cancer patients. When treating recurrent cervical cancer patients with chemotherapy who had prior radiotherapy, especially for those experienced external beam radiation therapy, essential attention and timely intervention are recommended to ensure completion of chemotherapy and clinical efficacy.
在线阅读     查看/发表评论  下载PDF阅读器